Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
Journal of the National Cancer Institute|December 9, 1997
P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapyH S Chan, T M Grogan, G Haddad, et al.Seminars in Oncology|September 1, 1986
First-line therapy with VP-16 and cisplatin for small-cell lung cancerW K Evans, F A Shepherd, R Feld, et al.Cancer Treatment Reports|February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinomaR Feld, W K Evans, F A Shepherd, et al.Carcinogenesis|June 29, 1999
Oxazepam is mutagenic in vivo in Big Blue transgenic miceB S Shane, J G deBoer, B W Glickman, et al.American Journal of Hospital Pharmacy|February 1, 1986
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugsP G Tuffnell, M T Gannon, A Dong, et al.BJU International|April 18, 2003
Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?B K Yap, R Choo, G Deboer, et al.Journal of the American Academy of Dermatology|February 1, 1987
Metastatic squamous cell carcinoma in linear porokeratosis of MibelliA Z Lozinski, B K Fisher, J B Walter, et al.Molecular & General Genetics : MGG|July 2, 1998
DNA replication is completed in Saccharomyces cerevisiae cells that lack functional Cdc14, a dual-specificity protein phosphataseP J Fitzpatrick, J H Toyn, J B Millar, et al.Journal of the Irish Dental Association|January 1, 1997
Eastern Health Board Regional Orthodontic Service: an initial auditP A Dowling, P J Fitzpatrick, M T Garvey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
VP-16 and cisplatin as first-line therapy for small-cell lung cancerW K Evans, F A Shepherd, R Feld, et al.Pageof 13